Valeo Pharma (VPH.C) secures exclusive licensing deal for leading multi-million dollar drug

(2:11)

Valeo Pharma Immune Booster Now Available In ~300 Loblaws Stores...

(18:28)

To Invest or Not: Valeo Pharma (VPH.C)

(3:44)

Valeo Pharma hits record 2nd quarter revenue as demand for Asthma products continues to rise

(5:11)

Valeo Pharma (VPH.C) stocks increase over 200% in a month! What is it they do?

(3:14)

Valeo Pharma Inc. Opens the Market Monday, May 9, 2022

(21)

A Beginner’s Guide to Pharma Consulting

(20:21)

Pharma CEO Admits: Our Business is Profit, Not Helping Sick People

(3:14)

Worst ever Big Pharma acquisition? | DW News

(27:8)

AGORACOM Beyond The Expert Welcomes Venture Capitalist Leigh Hughes

(41:19)

A Valeant Tug of War

(3:57)

8 Jobs in Hospitals in Canada anyone can apply I Easiest to get good paying jobs in Canada

(17:13)

Teva Pharma CEO: Majority of momentum came from innovative business, not GLP-1s

(4:3)

Pharma Biotech Valuation Model

(7:54)

Dispositif Breezhaler et Handihaler Traitement inhalé

(4:40)

Valeo Pharma (VPH.C) revisited - Investor Roundtable

(11:36)

Valeo Pharma (VPH.C) president \u0026 CEO Steve Saviuk \u0026 Novartis Agreement (Ep 48) FG/JV

(11:33)

Valeo Pharma (VPH.C) president and CEO, Steve Saviuk, demystifies specialty pharma (Ep 5) FG/JV

(18:1econd)

Valeo Pharma announces its Onstryv product receives public reimbursement in Quebec

(2:43)

Valeo Pharma CEO credits Enerzair for strong position on Canada’s top-growing companies list

(4:35)

Valeo Pharma closes 40-million-dollar financing to support 3 new drugs added to portfolio

(5:9)

Valeo Pharma (VPH.C) president \u0026 CEO Steve Saviuk explains specialty pharma (Ep 32) FG/JV

(15:10)

Video roundtable: Valeo Pharma's (VPH.C) innovative specialty pharmaceutical business model

(11:10)

Steve Saviuk of Valeo Pharma talks about acquiring new therapeutic drugs and record Q3 revenue

(8:14)

What Gives Valeo Pharma A Competitive Advantage In The $700M CAD / Year Asthma Market?

(1:53)

Valeo Pharma announces company has filed new drug submission with Health Canada for sabizabulin

(2:46)

Valeo Pharma (VPH.C) CEO Steve Saviuk talks specialty pharma opportunity (Ep4) Chris' Corner

(28:10)

Valeo Pharma’s Steve Saviuk on Hesperidin and reducing the risk of securing COVID-19

(8:58)

Valeo Pharma’s Asthma therapies Enerzair and Atectura now publicly covered in Quebec and Nova Scotia

(3:9)